Cargando…

M7G-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patients

BACKGROUND: N7-methylguanosine (m7G) is closely associated with tumor prognosis and immune response in many cancer types. The correlation between m7G and bladder cancer (BC) needs further study. We aimed to orchestrate molecular subtypes and identify key genes for BC from the perspective of m7G. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Deng-xiong, Feng, De-chao, Wang, Xiao-ming, Wu, Rui-cheng, Zhu, Wei-zhen, Chen, Kai, Han, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893617/
https://www.ncbi.nlm.nih.gov/pubmed/36732869
http://dx.doi.org/10.1186/s40001-023-01012-x
_version_ 1784881564367192064
author Li, Deng-xiong
Feng, De-chao
Wang, Xiao-ming
Wu, Rui-cheng
Zhu, Wei-zhen
Chen, Kai
Han, Ping
author_facet Li, Deng-xiong
Feng, De-chao
Wang, Xiao-ming
Wu, Rui-cheng
Zhu, Wei-zhen
Chen, Kai
Han, Ping
author_sort Li, Deng-xiong
collection PubMed
description BACKGROUND: N7-methylguanosine (m7G) is closely associated with tumor prognosis and immune response in many cancer types. The correlation between m7G and bladder cancer (BC) needs further study. We aimed to orchestrate molecular subtypes and identify key genes for BC from the perspective of m7G. METHODS: RNA-seq and clinical data of BC patients were extracted from TCGA and GSE13507 datasets. The patients were subtyped by “ConsensusClusterPlus” and “limma.” The clusters were validated by the Kaplan‒Meier curves, univariable and multivariate Cox regression models, the concordance index, and calibration curves. The immunotherapy response was evaluated by immune checkpoints, immune infiltration, TIDE score, and IMvigor210 cohort. Genomics of Drug Sensitivity in Cancer was utilized to predict the chemotherapy response between the clusters. RESULTS: The m7G-related cluster was ultimately established by EIF4G1, NUDT11, NUDT10, and CCNB1. The independent prognostic value of the m7G-related cluster was validated by the TCGA and GSE13507 datasets. The cluster was involved in immune-associated pathways, such as neutrophil degranulation, antigen processing cross-presentation, and signaling by interleukins pathways. Meanwhile, cluster 2 was positively correlated with many immune checkpoints, such as CD274, CTLA4, HAVCR2, LAG3, PDCD1, and PDCD1LG2. The cluster 2 was significantly correlated with a higher TIDE score than the cluster 1. Furthermore, in the IMvigor210 cohort, patients in the cluster 1 had a higher response rate than those in the cluster 2. Patients in the cluster 2 were sensitive to many chemotherapies. CONCLUSIONS: We successfully determined molecular subtypes and identified key genes for BC from the perspective of m7G, thereby providing a roadmap for the evolution of immunotherapy and precision medicine. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40001-023-01012-x.
format Online
Article
Text
id pubmed-9893617
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98936172023-02-03 M7G-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patients Li, Deng-xiong Feng, De-chao Wang, Xiao-ming Wu, Rui-cheng Zhu, Wei-zhen Chen, Kai Han, Ping Eur J Med Res Research BACKGROUND: N7-methylguanosine (m7G) is closely associated with tumor prognosis and immune response in many cancer types. The correlation between m7G and bladder cancer (BC) needs further study. We aimed to orchestrate molecular subtypes and identify key genes for BC from the perspective of m7G. METHODS: RNA-seq and clinical data of BC patients were extracted from TCGA and GSE13507 datasets. The patients were subtyped by “ConsensusClusterPlus” and “limma.” The clusters were validated by the Kaplan‒Meier curves, univariable and multivariate Cox regression models, the concordance index, and calibration curves. The immunotherapy response was evaluated by immune checkpoints, immune infiltration, TIDE score, and IMvigor210 cohort. Genomics of Drug Sensitivity in Cancer was utilized to predict the chemotherapy response between the clusters. RESULTS: The m7G-related cluster was ultimately established by EIF4G1, NUDT11, NUDT10, and CCNB1. The independent prognostic value of the m7G-related cluster was validated by the TCGA and GSE13507 datasets. The cluster was involved in immune-associated pathways, such as neutrophil degranulation, antigen processing cross-presentation, and signaling by interleukins pathways. Meanwhile, cluster 2 was positively correlated with many immune checkpoints, such as CD274, CTLA4, HAVCR2, LAG3, PDCD1, and PDCD1LG2. The cluster 2 was significantly correlated with a higher TIDE score than the cluster 1. Furthermore, in the IMvigor210 cohort, patients in the cluster 1 had a higher response rate than those in the cluster 2. Patients in the cluster 2 were sensitive to many chemotherapies. CONCLUSIONS: We successfully determined molecular subtypes and identified key genes for BC from the perspective of m7G, thereby providing a roadmap for the evolution of immunotherapy and precision medicine. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40001-023-01012-x. BioMed Central 2023-02-02 /pmc/articles/PMC9893617/ /pubmed/36732869 http://dx.doi.org/10.1186/s40001-023-01012-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Deng-xiong
Feng, De-chao
Wang, Xiao-ming
Wu, Rui-cheng
Zhu, Wei-zhen
Chen, Kai
Han, Ping
M7G-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patients
title M7G-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patients
title_full M7G-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patients
title_fullStr M7G-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patients
title_full_unstemmed M7G-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patients
title_short M7G-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patients
title_sort m7g-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893617/
https://www.ncbi.nlm.nih.gov/pubmed/36732869
http://dx.doi.org/10.1186/s40001-023-01012-x
work_keys_str_mv AT lidengxiong m7grelatedmolecularsubtypescanpredicttheprognosisandcorrelatewithimmunotherapyandchemotherapyresponsesinbladdercancerpatients
AT fengdechao m7grelatedmolecularsubtypescanpredicttheprognosisandcorrelatewithimmunotherapyandchemotherapyresponsesinbladdercancerpatients
AT wangxiaoming m7grelatedmolecularsubtypescanpredicttheprognosisandcorrelatewithimmunotherapyandchemotherapyresponsesinbladdercancerpatients
AT wuruicheng m7grelatedmolecularsubtypescanpredicttheprognosisandcorrelatewithimmunotherapyandchemotherapyresponsesinbladdercancerpatients
AT zhuweizhen m7grelatedmolecularsubtypescanpredicttheprognosisandcorrelatewithimmunotherapyandchemotherapyresponsesinbladdercancerpatients
AT chenkai m7grelatedmolecularsubtypescanpredicttheprognosisandcorrelatewithimmunotherapyandchemotherapyresponsesinbladdercancerpatients
AT hanping m7grelatedmolecularsubtypescanpredicttheprognosisandcorrelatewithimmunotherapyandchemotherapyresponsesinbladdercancerpatients